Actively Recruiting
A Study of Endoscopic Sleeve Gastroplasty Combined with Duodenal pulsENDO for Treating Obesity and Type 2 Diabetes
Led by Chinese University of Hong Kong · Updated on 2026-09-16
20
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, effectiveness, and mechanisms of combining Endoscopic Sleeve Gastroplasty ESG with the duodenal pulsENDO procedure in adults with obesity and type 2 diabetes mellitus T2DM. This feasibility study enrolls individuals with these conditions to follow their progress over two years, aiming to explore this novel combined approach. Participants will undergo both the pulsENDO and ESG procedures in the same session. The pulsENDO uses a catheter to deliver pulsed electric fields to the duodenum to promote cell regeneration, treating approximately 10-18 cm of the duodenum. ESG reduces stomach volume through endoscopic suturing to create a restrictive sleeve. This combined intervention is being studied as a new treatment approach. Throughout the study, participants will be followed for two years. Researchers will assess changes in diabetic medications at 12 months, as well as weight loss, body fat percentage, quality of life, microbiome changes, improvement in liver condition MAFLD, and blood sugar control HbA1c at 24 months. Safety will be monitored through adverse event tracking within 30 days post-procedure, with participants undergoing regular evaluations to measure these outcomes.
CONDITIONS
Brief Title
Endoscopic Sleeve Gastroplasty Plus Duodenal pulsENDO for Obese T2DM
Research Team
S
Stephen Ng
I
Ivy Study coordinator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here